Showing results (321-330 of 1,648) with videos related to
Sort By:
Pageof 165
Hepatology International|August 24, 2022
A deep learning model with incorporation of microvascular invasion area as a factor in predicting prognosis of hepatocellular carcinoma after R0 hepatectomyKang Wang, Yanjun Xiang, Jiangpeng Yan, et al.Hepatology International|August 24, 2022
Prognosis factors of predicting survival in spontaneously ruptured hepatocellular carcinomaPeng Wang, Abraham S Moses, Chao Li, et al.Hepatology International|August 10, 2022
A somatic mutation-derived LncRNA signatures of genomic instability predicts the prognosis and tumor microenvironment immune characters in hepatocellular carcinomaChuan Jin, Jian-Sen Zhao, Xu-Qi Huang, et al.Hepatology International|May 25, 2020
Clinical practice guidance for hepatology and liver transplant providers during the COVID-19 pandemic: APASL expert panel consensus recommendations, George Lau, Manoj SharmaHepatology International|June 24, 2020
Development and validation of a clinical and laboratory-based nomogram to predict nonalcoholic fatty liver diseaseChao Cen, Wenpu Wang, Songfeng Yu, et al.Hepatology International|August 17, 2021
Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis BHye Won Lee, Young Youn Cho, Hyein Lee, et al.Hepatology International|December 9, 2025
Efficacy and safety of entecavir, peginterferon alfa-2b and GM-CSF combination therapy: the anchor randomized controlled trialDi Wu, Da Huang, Shifang Peng, et al.Hepatology International|November 27, 2025
Metabolic dysfunction-associated steatotic liver disease and adverse pregnancy outcomes: a nationwide cohort studyYoung Mi Jung, Taesu Kim, Min-Jeong Oh, et al.Hepatology International|November 20, 2025
Enhancing post-TIPS hepatic encephalopathy risk stratification: a hybrid TabPFN model leveraging radiomics, deep transfer learning features, and MELD scoreLei Miao, He Zhao, Xiaowu Zhang, et al.Hepatology International|November 19, 2025
Inhibition of the U12-type splicing factor ZCRB1 mediates retention of the USP21 minor intron to suppress malignant progression in hepatocellular carcinomaFan Zhang, Zhipeng Yao, Hengjun Gao, et al.Pageof 165